Celgene, Scripps Spinout Vividion Launch Small-Molecule Collaboration

Celgene will partner with Vividion Therapeutics to identify and develop small molecules against targets for a variety of oncology, inflammatory, and neurodegenerative indications, Vividion said today.The companies have launched a strategic research collaboration that will generate for Vividion at least $101 million upfront, including an unspecified equity investment from Celgene.Vividion said it will be joined by Celgene in advancing new small molecules that function through the ubiquitin protea